A carcinoembryonic antigen polynucleotide vaccine for human clinical use.

Cancer gene therapy

Volumn 2, Issue 1, 1995, Pages 33-38

  Conry, R M ^a   LoBuglio, A F ^a   Loechel, F ^a   Moore, S E ^a   Sumerel, L A ^a   Barlow, D L ^a   Pike, J ^a   Curiel, D T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CANCER ANTIBODY; CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; HYBRID PROTEIN; RECOMBINANT VACCINE; SYNTHETIC DNA; TUMOR ANTIGEN;

ADENOCARCINOMA; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CLINICAL TRIAL; COLON TUMOR; COLORECTAL TUMOR; CYTOMEGALOVIRUS; ENHANCER REGION; FEMALE; GENE VECTOR; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; METASTASIS; MOUSE; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PROMOTER REGION; VACCINATION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CYTOMEGALOVIRUS; DNA, COMPLEMENTARY; ENHANCER ELEMENTS (GENETICS); FEMALE; GENES, SYNTHETIC; GENETIC VECTORS; GRAFT REJECTION; HUMANS; INJECTIONS, INTRAMUSCULAR; ISOANTIBODIES; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VACCINATION; VACCINES, SYNTHETIC;

EID: 0029261923     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)